Glossary of Terms

Introduction

Parts of this glossary have been taken or adapted from the National Cancer Institute’s Cancer Dictionary and the American Breast Cancer Society’s Breast Cancer Dictionary.

This glossary does not contain definitions of medications. To learn more about specific medications, visit the website of the National Cancer Institute.

Many thanks to the healthcare practitioners who reviewed portions of this glossary:

• Mechelle Barrick, RN, BSN, OCN, Greater Baltimore Medical Center
• Debra S. Copit, MD, Albert Einstein Medical Center
• Ann L. Honebrink, MD, Penn Health at Radnor
• Isabel I. Law, RN, South Carolina Comprehensive Breast Center
• Judith Macon, RN, MA, Suburban Hospital Cancer Program
• Suzanne McGettigan Bensman, MSN, CRNP, AOCN
• Lisa McGinty, RN, BSN, Abramson Cancer Center, University of Pennsylvania
• Maria Rocktashel, MSN, CRNP, Delaware Valley Surgical Associates
• Lynn M. Schuchter, MD, University of Pennsylvania Abramson Cancer Center
• Michele D. Stolper, Dana-Farber Cancer Institute
• Fionda N. Williams, RN, BSN, Baltimore City Cancer Program

Glossary

4-hydroxytamoxifen

A form of the medication tamoxifen (brand name: Nolvadex) that is made by the body after taking tamoxifen. It can also be made in the laboratory, and may help decrease breast density. A topical form of 4-hydroxytamoxifen is being studied in breast cancer screening.

Top of Page